Amneal Pharmaceuticals, Inc. AMRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $197.66M+234% | $282.03M+155% | $201.25M+172% | $71.54M+63.5% | $59.19M+27.2% | ||
| $4.17M-36.6% | $28.84M+267% | $34.73M+700% | $9.64M+64.7% | $6.58M+29.2% | ||
| -$44.01M-108% | $10.34M-63.9% | $77.61M— | $53.76M-46.6% | -$21.15M-138% | ||
| $641.62M+6.7% | $606.3M-1.0% | $614.5M+3.0% | $608.97M+5.8% | $601.43M+5.4% | ||
| $103.09M+16.5% | $98.4M+21.9% | $101.51M+23.9% | $85.3M+4.5% | $88.52M+1.4% | ||
| $1.8B+19.0% | $1.91B+20.4% | $1.84B+21.5% | $1.58B+6.7% | $1.51B+9.4% | ||
| $444.61M+4.1% | $442.95M+4.2% | $434.99M+0.9% | $440.33M+3.5% | $427.23M-2.9% | ||
| $593.8M-0.6% | $595.47M-0.3% | $595.95M-0.4% | $597.41M-0.2% | $597.5M-0.2% | ||
| $534.87M-22.4% | $563.5M-23.1% | $587.94M-24.6% | $649.55M-20.8% | $689.14M-19.8% | ||
| $54.88M+20.8% | $57.81M-3.9% | $39.46M+8.8% | $44.85M-41.8% | $45.42M-38.4% | ||
| $3.54B+5.2% | $3.68B+5.1% | $3.6B+4.0% | $3.42B-2.5% | $3.37B-2.6% | ||
| $6.2M-80.5% | $6.76M-97.0% | $7.2M-96.8% | $31.18M-86.2% | $31.79M-5.6% | ||
| —— | $58.8M+25.0% | —— | —— | —— | ||
| $728.05M-32.3% | $881.63M-22.0% | $862.11M-21.3% | $1.11B-0.6% | $1.08B+28.9% | ||
| $2.57B+19.1% | $2.57B+18.7% | $2.57B+18.3% | $2.15B-1.4% | $2.15B-9.4% | ||
| —— | $58.37M-2.9% | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $2.77B+18.0% | $2.79B+15.5% | $2.78B+15.9% | $2.36B-1.6% | $2.35B-11.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $536.3M-1.7% | $571.79M+2.1% | $563.36M+1.8% | $554.62M+1.6% | $545.81M+1.3% | ||
| -$472.75M+20.5% | -$535.01M+11.9% | -$570.08M+1.0% | -$572.45M+0.6% | -$594.87M-2.2% | ||
| -$112.15M-30.8% | -$110.73M-69.0% | -$105.88M-43.5% | -$97.43M-220% | -$85.74M-262% | ||
| -$558K-67.6% | -$535K-118% | -$497K-268% | -$415K-1,629% | -$333K-451% | ||
| -$45.41M+65.5% | -$70.79M+35.2% | -$109.46M-17.2% | -$112.12M-95.1% | -$131.67M-107% | ||
| $3.54B+5.2% | $3.68B+5.1% | $3.6B+4.0% | $3.42B-2.5% | $3.37B-2.6% | ||
| —— | —— | —— | —— | —— | ||
| $54.88M+20.8% | $57.81M-3.9% | $39.46M+8.8% | $44.85M-41.8% | $45.42M-38.4% | ||
| $534.87M-22.4% | $563.5M-23.1% | $587.94M-24.6% | $649.55M-20.8% | $689.14M-19.8% | ||
| $54.88M+20.8% | $57.81M-3.9% | $39.46M+8.8% | $44.85M-41.8% | $45.42M-38.4% | ||
| $54.88M+20.8% | $57.81M-3.9% | $39.46M+8.8% | $44.85M-41.8% | $45.42M-38.4% | ||
| $70.02M-4.1% | $71.82M-16.0% | $74.48M-12.9% | $74.48M-12.9% | $72.98M-14.6% | ||
| $10.55M-75.7% | $43.26M+36.2% | $40.6M+34.5% | $41.52M+35.1% | $43.5M+44.4% | ||
| $2.57B+17.7% | $2.69B+7.9% | $2.57B+7.5% | $2.18B-9.4% | $2.19B-9.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $70.02M-4.1% | $71.82M-16.0% | $74.48M-12.9% | $74.48M-12.9% | $72.98M-14.6% | ||
| -$558K-67.6% | -$535K-118% | -$497K-268% | -$415K-1,629% | -$333K-451% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amneal Pharmaceuticals, Inc.'s total assets?
- Amneal Pharmaceuticals, Inc. (AMRX) holds $3.5B in total assets, up 5.2% year over year.
- How much debt does Amneal Pharmaceuticals, Inc. have?
- Amneal Pharmaceuticals, Inc. carries $2.6B in total debt against -$45.4M of shareholders' equity, a debt-to-equity ratio of 127.90.
- How much cash does Amneal Pharmaceuticals, Inc. have?
- Amneal Pharmaceuticals, Inc. holds $197.7M in cash and equivalents.
- Can Amneal Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.47 — current assets exceed current liabilities.
- Where does Amneal Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
